| Year |
Citation |
Score |
| 2017 |
Plavén-Sigray P, Hedman E, Victorsson P, Matheson GJ, Forsberg A, Djurfeldt DR, Rück C, Halldin C, Lindefors N, Cervenka S. Extrastriatal dopamine D2-receptor availability in social anxiety disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28377075 DOI: 10.1016/J.Euroneuro.2017.03.007 |
0.335 |
|
| 2014 |
Tiger M, Rück C, Forsberg A, Varrone A, Lindefors N, Halldin C, Farde L, Lundberg J. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Research. 223: 164-70. PMID 24916155 DOI: 10.1016/J.Pscychresns.2014.05.011 |
0.328 |
|
| 2012 |
Cervenka S, Hedman E, Ikoma Y, Djurfeldt DR, Rück C, Halldin C, Lindefors N. Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Translational Psychiatry. 2: e120. PMID 22832965 DOI: 10.1038/Tp.2012.40 |
0.358 |
|
| 2006 |
Radu D, Tomkinson B, Zachrisson O, Weber G, de Belleroche J, Hirsch S, Lindefors N. Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10). Brain Research. 1104: 175-82. PMID 16822484 DOI: 10.1016/J.Brainres.2006.05.059 |
0.828 |
|
| 2001 |
Radu D, Brodin E, Weber G, Lindefors N. Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine. Brain Research. 908: 197-203. PMID 11454330 DOI: 10.1016/S0006-8993(01)02648-8 |
0.368 |
|
| 2000 |
Zachrisson O, Nomikos GG, Marcus MM, Svensson TH, Lindefors N. Effects of antipsychotic drugs on cholecystokinin and preprotachykinin (substance P) mRNA expression in the rat hippocampal formation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 10: 355-63. PMID 10974607 DOI: 10.1016/S0924-977X(00)00093-6 |
0.806 |
|
| 2000 |
Radu D, Zachrisson O, de Belleroche J, Wendt K, Hirsh S, Lindefors N. Cholecystokinin in CCKB receptor mRNA isoforms: Expression in post-mortem monkey and human brain — alterations following schizophrenia Schizophrenia Research. 41: 254-255. DOI: 10.1016/S0920-9964(00)90943-5 |
0.805 |
|
| 1999 |
Zachrisson O, de Belleroche J, Wendt KR, Hirsch S, Lindefors N. Cholecystokinin CCK(B) receptor mRNA isoforms: expression in schizophrenic brains. Neuroreport. 10: 3265-8. PMID 10599831 |
0.799 |
|
| 1998 |
Zachrisson O, Lindefors N, Brené S. A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Brain Research. Molecular Brain Research. 60: 291-5. PMID 9757066 DOI: 10.1016/S0169-328X(98)00191-0 |
0.789 |
|
| 1997 |
Falkenberg T, Lindefors N, O'Connor WT, Zachrisson O, Camilli F, Ungerstedt U. GABA release and GAD67 mRNA expression in rat hippocampus following entorhinal cortex activation. Brain Research. Molecular Brain Research. 48: 413-6. PMID 9332739 DOI: 10.1016/S0169-328X(97)00185-X |
0.803 |
|
| 1997 |
Lindefors N, Barati S, O'Connor WT. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Research. 759: 205-12. PMID 9221938 DOI: 10.1016/S0006-8993(97)00255-2 |
0.403 |
|
| 1997 |
Marcus MM, Nomikos GG, Malmerfelt A, Zachrisson O, Lindefors N, Svensson TH. Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat. Brain Research. Molecular Brain Research. 45: 275-82. PMID 9149102 DOI: 10.1016/S0169-328X(96)00263-X |
0.821 |
|
| 1997 |
Zachrisson O, Mathé AA, Lindefors N. Decreased levels of preprotachykinin-A and tachykinin NK1 receptor mRNA in specific region of the rat striatum after electroconvulsive stimuli. European Journal of Pharmacology. 319: 191-5. PMID 9042590 DOI: 10.1016/S0014-2999(96)00861-8 |
0.821 |
|
| 1996 |
Zachrisson O, Mathé AA, Lindefors N. Effects of chronic lithium and electroconvulsive stimuli on cholecystokinin mRNA expression in the rat brain. Brain Research. Molecular Brain Research. 43: 347-50. PMID 9037553 DOI: 10.1016/S0169-328X(96)00247-1 |
0.821 |
|
| 1996 |
Falkenberg T, Lindefors N, Camilli F, Metsis M, Ungerstedt U. Glutamate release correlates with brain-derived neurotrophic factor and trkB mRNA expression in the CA1 region of rat hippocampus. Brain Research. Molecular Brain Research. 42: 317-27. PMID 9013789 DOI: 10.1016/S0169-328X(96)00134-9 |
0.751 |
|
| 1996 |
Zachrisson O, Falkenberg T, Lindefors N. Neuronal coexistence of trkB and glutamic acid decarboxylase67 mRNAs in rat hippocampus. Brain Research. Molecular Brain Research. 36: 169-73. PMID 9011754 DOI: 10.1016/0169-328X(95)00281-V |
0.815 |
|
| 1996 |
Zachrisson O, Lindefors N. [Cholecystokinin receptors. A target for tomorrow's psychopharmaceuticals?]. Lã¤Kartidningen. 93: 1225-7. PMID 8656838 |
0.756 |
|
| 1995 |
Smith S, Lindefors N, Hurd Y, Sharp T. Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat. Psychopharmacology. 120: 333-40. PMID 8524981 DOI: 10.1007/Bf02311181 |
0.448 |
|
| 1995 |
Lindefors N, Brodin E, Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience. 65: 661-70. PMID 7609868 DOI: 10.1016/0306-4522(94)00550-O |
0.393 |
|
| 1995 |
Zachrisson O, Mathé AA, Stenfors C, Lindefors N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neuroscience Letters. 194: 89-92. PMID 7478221 DOI: 10.1016/0304-3940(95)11735-F |
0.828 |
|
| 1995 |
Brené S, Hall H, Lindefors N, Karlsson P, Halldin C, Sedvall G. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors. Neuroscience. 67: 37-48. PMID 7477907 DOI: 10.1016/0306-4522(95)00037-J |
0.36 |
|
| 1995 |
Zachrisson O, Mathé AA, Stenfors C, Lindefors N. Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Brain Research. Molecular Brain Research. 31: 71-85. PMID 7476035 DOI: 10.1016/0169-328X(95)00033-O |
0.837 |
|
| 1994 |
Brené S, Herrera-Marschitz M, Persson H, Lindefors N. Expression of mRNAs encoding dopamine receptors in striatal regions is differentially regulated by midbrain and hippocampal neurons. Brain Research. Molecular Brain Research. 21: 274-82. PMID 8170351 DOI: 10.1016/0169-328X(94)90258-5 |
0.691 |
|
| 1994 |
Brené S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 985-98. PMID 8120638 DOI: 10.1523/Jneurosci.14-03-00985.1994 |
0.718 |
|
| 1994 |
Johnson AE, Liminga U, Lidén A, Lindefors N, Gunne LM, Wiesel FA. Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain. Neuroscience. 63: 1003-20. PMID 7535390 DOI: 10.1016/0306-4522(94)90568-1 |
0.315 |
|
| 1994 |
Brene S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue The Journal of Neuroscience. 14: 985-998. DOI: 10.1523/JNEUROSCI.14-03-00985.1994 |
0.801 |
|
| 1993 |
Johansson B, Ahlberg S, van der Ploeg I, Brené S, Lindefors N, Persson H, Fredholm BB. Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 347: 407-14. PMID 8510768 DOI: 10.1007/Bf00165391 |
0.63 |
|
| 1993 |
Lindefors N, Lindén A, Brené S, Sedvall G, Persson H. CCK peptides and mRNA in the human brain. Progress in Neurobiology. 40: 671-90. PMID 8484007 DOI: 10.1016/0301-0082(93)90010-P |
0.641 |
|
| 1993 |
Falkenberg T, Metsis M, Timmusk T, Lindefors N. Entorhinal cortex regulation of multiple brain-derived neurotrophic factor promoters in the rat hippocampus. Neuroscience. 57: 891-6. PMID 8309550 DOI: 10.1016/0306-4522(93)90034-D |
0.673 |
|
| 1993 |
Brené S, Lindefors N, Herrera-Marschitz M, Persson H. Differential regulation of preprotachykinin-A mRNA expression in striatum by excitation of hippocampal neurons. The European Journal of Neuroscience. 5: 839-45. PMID 8281296 DOI: 10.1111/J.1460-9568.1993.Tb00936.X |
0.719 |
|
| 1993 |
Lindefors N. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 17: 887-903. PMID 8278600 DOI: 10.1016/0278-5846(93)90018-N |
0.43 |
|
| 1992 |
Boatell LL, Lindefors N, Ballarin M, Ernfors P, Mahy N, Persson H. Activation of basal forebrain cholinergic neurons differentially regulates brain-derived neurotrophic factor mRNA expression in different projection areas. Neuroscience Letters. 136: 203-8. PMID 1641192 DOI: 10.1016/0304-3940(92)90049-D |
0.772 |
|
| 1992 |
Lindefors N, Boatell ML, Mahy N, Persson H. Widespread neuronal degeneration after ibotenic acid lesioning of cholinergic neurons in the nucleus basalis revealed by in situ hybridization. Neuroscience Letters. 135: 262-4. PMID 1625807 DOI: 10.1016/0304-3940(92)90451-C |
0.633 |
|
| 1992 |
Lindefors N, Hurd YL, O'Connor WT, Brené S, Persson H, Ungerstedt U. Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens. Neuroscience. 48: 439-48. PMID 1603328 DOI: 10.1016/0306-4522(92)90503-T |
0.74 |
|
| 1992 |
Lindefors N, Ernfors P, Falkenberg T, Persson H. Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and beta-nerve growth factor mRNA in rat hippocampus. Experimental Brain Research. 88: 78-90. PMID 1541364 DOI: 10.1007/Bf02259130 |
0.811 |
|
| 1992 |
Kopp J, Lindefors N, Brené S, Hall H, Persson H, Sedvall G. Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain. Neuroscience. 47: 771-9. PMID 1533704 DOI: 10.1016/0306-4522(92)90028-Z |
0.692 |
|
| 1992 |
Falkenberg T, Ernfors P, Persson H, Lindefors N. Cortical transynaptic activation of tyrosine kinase receptor trkB messenger RNA expression in rat hippocampus. Neuroscience. 51: 883-9. PMID 1488128 DOI: 10.1016/0306-4522(92)90527-9 |
0.796 |
|
| 1992 |
Brené S, Lindefors N, Ballarin M, Persson H. Kainic acid-mediated increase of preprotachykinin-A messenger RNA expression in the rat hippocampus and a region-selective attenuation by dexamethasone. Neuroscience. 50: 611-8. PMID 1436505 DOI: 10.1016/0306-4522(92)90450-G |
0.687 |
|
| 1992 |
Falkenberg T, Mohammed AK, Henriksson B, Persson H, Winblad B, Lindefors N. Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neuroscience Letters. 138: 153-6. PMID 1407655 DOI: 10.1016/0304-3940(92)90494-R |
0.756 |
|
| 1992 |
Sedvall CG, Farde L, Hall H, Halldin C, Karlsson P, Brene S, Lindefors N, Persson H, Chipkin RE, Ehrlich M. Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain. Clinical Neuropharmacology. 15: 466A-467A. PMID 1386781 |
0.786 |
|
| 1992 |
Hurd YL, Lindefors N, Brodin E, Brené S, Persson H, Ungerstedt U, Hökfelt T. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission. Brain Research. 578: 317-26. PMID 1354999 DOI: 10.1016/0006-8993(92)90264-A |
0.739 |
|
| 1992 |
Brené S, Lindefors N, Persson H. Midbrain dopamine neurons regulate preprotachykinin-A mRNA expression in the rat forebrain during development. Brain Research. Molecular Brain Research. 14: 13-9. PMID 1323010 DOI: 10.1016/0169-328X(92)90004-U |
0.723 |
|
| 1992 |
Lindefors N, Ballarin M, Ernfors P, Falkenberg T, Persson H. Stimulation of glutamate receptors increases expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Annals of the New York Academy of Sciences. 648: 296-9. PMID 1322082 DOI: 10.1111/J.1749-6632.1992.Tb24561.X |
0.825 |
|
| 1992 |
Lindefors N. Amphetamine and haloperidol modulate preprotachykinin A mRNA expression in rat nucleus accumbens and caudate-putamen. Brain Research. Molecular Brain Research. 13: 151-4. PMID 1315912 DOI: 10.1016/0169-328X(92)90055-G |
0.483 |
|
| 1992 |
Lindefors N, Falkenberg T, Ernfors P, Mouhammed A, Henriksson B, Vinblad B, Persson H. BDNF, NGF and TrkB mRNA EXPRESSION IN RAT HIPPOCAMPUS: EFFECTS OF AFFERENT NEURONAL ACTIVATION AND ENVIRONMENTAL STIMULI Clinical Neuropharmacology. 15: 223B. DOI: 10.1097/00002826-199202001-00430 |
0.81 |
|
| 1992 |
Lindefors N, Brené S, Kopp J, Ehrlich M, Greengard P, Hall H, Sedvall G, Persson H. EXPRESSION OF mRNAs ENCODING THE PHOSPHOPROTEINS ARPP-16/19, ARPP-21 AND DARPP-32 IN THE HUMAN BRAIN Clinical Neuropharmacology. 15: 131B. DOI: 10.1097/00002826-199202001-00252 |
0.805 |
|
| 1992 |
Lindefors N, Brené S, Kopp J, Hall H, Persson H, Sedvall G. NEUROLEPTIC TREATMENT AND DOPAMINE LESIONS MODULATE POST-SYNAPTIC EXPRESSION OF DOPAMINE D2 RECEPTOR mRNA IN RAT BRAIN. Clinical Neuropharmacology. 15: 131B. DOI: 10.1097/00002826-199202001-00251 |
0.803 |
|
| 1991 |
Lindefors N, Brené S, Kopp J, Lindén A, Brodin E, Sedvall G, Persson H. Distribution of cholecystokinin mRNA and peptides in the human brain. Neuroscience. 42: 813-21. PMID 1956517 DOI: 10.1016/0306-4522(91)90046-Q |
0.701 |
|
| 1991 |
O'Connor WT, Lindefors N, Brené S, Herrera-Marschitz M, Persson H, Ungerstedt U. Short-term dopaminergic regulation of GABA release in dopamine deafferented caudate-putamen is not directly associated with glutamic acid decarboxylase gene expression. Neuroscience Letters. 128: 66-70. PMID 1922949 DOI: 10.1016/0304-3940(91)90761-H |
0.719 |
|
| 1991 |
BallarÃn M, Ernfors P, Lindefors N, Persson H. Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Experimental Neurology. 114: 35-43. PMID 1915733 DOI: 10.1016/0014-4886(91)90082-N |
0.78 |
|
| 1991 |
Lindefors N, Brodin K, Stiller CO, Persson H, Brodin E. Repeated electroconvulsive shock increases tachykinin and cholecystokinin mRNA expression in ventral periaqueductal gray. Neuroscience. 45: 73-80. PMID 1754069 DOI: 10.1016/0306-4522(91)90104-V |
0.655 |
|
| 1990 |
Lindefors N, Brené S, Herrera-Marschitz M, Persson H. Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons. Experimental Brain Research. 80: 489-500. PMID 2387350 DOI: 10.1007/Bf00227990 |
0.708 |
|
| 1990 |
Lindefors N, Brené S, Persson H. Increased expression of glutamic acid decarboxylase mRNA in rat substantia nigra after an ibotenic acid lesion in the caudate-putamen. Brain Research. Molecular Brain Research. 7: 207-12. PMID 2159580 DOI: 10.1016/0169-328X(90)90029-D |
0.707 |
|
| 1990 |
Brené S, Lindefors N, Herrera-Marschitz M, Persson H. Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen. Experimental Brain Research. 83: 96-104. PMID 2150048 DOI: 10.1007/Bf00232197 |
0.7 |
|
| 1990 |
Brené S, Lindefors N, Friedman WJ, Persson H. Preprotachykinin A mRNA expression in the rat brain during development. Brain Research. Developmental Brain Research. 57: 151-62. PMID 1981494 DOI: 10.1016/0165-3806(90)90041-V |
0.694 |
|
| 1990 |
Lindefors N, Brené S, Herrera-Marschitz M, Persson H. Regulation of neuropeptide Y gene expression in rat brain. Annals of the New York Academy of Sciences. 611: 175-85. PMID 1978997 |
0.702 |
|
| 1990 |
Lindefors N, Ungerstedt U. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neuroscience Letters. 115: 248-52. PMID 1978265 DOI: 10.1016/0304-3940(90)90463-J |
0.573 |
|
| 1990 |
Reid MS, Herrera-Marschitz M, Hökfelt T, Lindefors N, Persson H, Ungerstedt U. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms. Experimental Brain Research. 82: 293-303. PMID 1704847 DOI: 10.1007/Bf00231249 |
0.706 |
|
| 1990 |
Ernfors P, Lindefors N, Chan-Palay V, Persson H. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the alzheimer type Dementia and Geriatric Cognitive Disorders. 1: 138-145. DOI: 10.1159/000107133 |
0.607 |
|
| 1989 |
Brené S, Lindefors N, Kopp J, Sedvall G, Persson H. Regional distribution of neuropeptide Y mRNA in postmortem human brain. Brain Research. Molecular Brain Research. 6: 241-9. PMID 2593779 DOI: 10.1016/0169-328X(89)90070-3 |
0.707 |
|
| 1989 |
Amberg G, Lindefors N. Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics. Journal of Pharmacological Methods. 22: 157-83. PMID 2586112 DOI: 10.1016/0160-5402(89)90012-0 |
0.31 |
|
| 1989 |
Lindefors N, Amberg G, Ungerstedt U. Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. Journal of Pharmacological Methods. 22: 141-56. PMID 2586111 DOI: 10.1016/0160-5402(89)90011-9 |
0.511 |
|
| 1989 |
Lindefors N, Brene S, Herrera-Marschitz M, Persson H. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Experimental Brain Research. 77: 611-20. PMID 2572447 DOI: 10.1007/Bf00249614 |
0.823 |
|
| 1989 |
Lindefors N, Brodin E, Ungerstedt U. Amphetamine facilitates the in vivo release of neurokinin A in the nucleus accumbens of the rat. European Journal of Pharmacology. 160: 417-20. PMID 2540996 DOI: 10.1016/0014-2999(89)90100-3 |
0.536 |
|
| 1989 |
Lindefors N, Brodin E, Ungerstedt U. Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra. European Journal of Pharmacology. 161: 95-8. PMID 2470596 DOI: 10.1016/0014-2999(89)90185-4 |
0.508 |
|
| 1989 |
Lindefors N, Brodin E, Tossman U, Segovia J, Ungerstedt U. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Experimental Brain Research. 74: 527-34. PMID 2468514 DOI: 10.1007/Bf00247354 |
0.555 |
|
| 1987 |
Lindefors N, Tossman U, Ungerstedt U. Subchronic haloperidol and sulpiride treatment induces region-specific changes in tissue levels of putative amino acid transmitters in rat brain. Neuroscience Letters. 74: 90-4. PMID 2882448 DOI: 10.1016/0304-3940(87)90057-7 |
0.579 |
|
| 1987 |
Lindefors N, Brodin E, Ungerstedt U. Microdialysis combined with a sensitive radioimmunoassay. A technique for studying in vivo release of neuropeptides. Journal of Pharmacological Methods. 17: 305-12. PMID 2441208 DOI: 10.1016/0160-5402(87)90044-1 |
0.498 |
|
| 1986 |
Lindefors N, Sharp T, Ungerstedt U. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat. European Journal of Pharmacology. 129: 401-4. PMID 3780852 DOI: 10.1016/0014-2999(86)90457-7 |
0.568 |
|
| 1986 |
Lindefors N, Brodin E, Ungerstedt U. Neurokinin A and substance P in striato-nigral neurons in rat brain. Neuropeptides. 8: 127-32. PMID 2429229 DOI: 10.1016/0143-4179(86)90039-9 |
0.59 |
|
| 1986 |
Lindefors N, Yamamoto Y, Pantaleo T, Lagercrantz H, Brodin E, Ungerstedt U. In vivo release of substance P in the nucleus tractus solitarii increases during hypoxia. Neuroscience Letters. 69: 94-7. PMID 2427979 DOI: 10.1016/0304-3940(86)90421-0 |
0.5 |
|
| 1986 |
Lindefors N, Brodin E, Ungerstedt U. Neuroleptic treatment induces region-specific changes in levels of neurokinin A and substance P in rat brain. Neuropeptides. 7: 265-80. PMID 2423911 DOI: 10.1016/0143-4179(86)90021-1 |
0.562 |
|
| 1985 |
Lindefors N, Brodin E, Theodorsson-Norheim E, Ungerstedt U. Calcium-dependent potassium-stimulated release of neurokinin A and neurokinin B from rat brain regions in vitro. Neuropeptides. 6: 453-61. PMID 2997657 DOI: 10.1016/0143-4179(85)90144-1 |
0.517 |
|
| 1985 |
Lindefors N, Brodin E, Theodorsson-Norheim E, Ungerstedt U. Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportions of tachykinins. Regulatory Peptides. 10: 217-30. PMID 2581287 DOI: 10.1016/0167-0115(85)90016-3 |
0.535 |
|
| 1983 |
Brodin E, Lindefors N, Ungerstedt U. Potassium evoked in vivo release of substance P in rat caudate nucleus measured using a new technique of brain dialysis and an improved substance P-radioimmunoassay. Acta Physiologica Scandinavica. Supplementum. 515: 17-20. PMID 6194653 |
0.45 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2003 |
Radu D, Ahlin A, Svanborg P, Lindefors N. Pentagastrin test for anxiety--psychophysiology and personality. Psychopharmacology. 166: 139-45. PMID 12529809 DOI: 10.1007/S00213-002-1316-7 |
0.277 |
|
| 2015 |
El Alaoui S, Ljótsson B, Hedman E, Kaldo V, Andersson E, Rück C, Andersson G, Lindefors N. Predictors of Symptomatic Change and Adherence in Internet-Based Cognitive Behaviour Therapy for Social Anxiety Disorder in Routine Psychiatric Care. Plos One. 10: e0124258. PMID 25893687 DOI: 10.1371/Journal.Pone.0124258 |
0.263 |
|
| 2002 |
Radu D, Ahlin A, Svanborg P, Lindefors N. Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels. Psychopharmacology. 161: 396-403. PMID 12073167 DOI: 10.1007/S00213-002-1044-Z |
0.262 |
|
| 2009 |
Bergström J, Andersson G, Karlsson A, Andréewitch S, Rück C, Carlbring P, Lindefors N. An open study of the effectiveness of Internet treatment for panic disorder delivered in a psychiatric setting. Nordic Journal of Psychiatry. 63: 44-50. PMID 18985514 DOI: 10.1080/08039480802191132 |
0.262 |
|
| 2010 |
Bergström J, Andersson G, Ljótsson B, Rück C, Andréewitch S, Karlsson A, Carlbring P, Andersson E, Lindefors N. Internet-versus group-administered cognitive behaviour therapy for panic disorder in a psychiatric setting: a randomised trial. Bmc Psychiatry. 10: 54. PMID 20598127 DOI: 10.1186/1471-244X-10-54 |
0.261 |
|
| 2011 |
Hedman E, Andersson G, Ljótsson B, Andersson E, Rück C, Mörtberg E, Lindefors N. Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial. Plos One. 6: e18001. PMID 21483704 DOI: 10.1371/Journal.Pone.0018001 |
0.26 |
|
| 2016 |
Pankowski S, Adler M, Andersson G, Lindefors N, Svanborg C. Group acceptance and commitment therapy (ACT) for bipolar disorder and co-existing anxiety - an open pilot study. Cognitive Behaviour Therapy. 1-15. PMID 27647353 DOI: 10.1080/16506073.2016.1231218 |
0.258 |
|
| 1986 |
Brodin E, Lindefors N, Dalsgaard CJ, Theodorsson-Norheim E, Rosell S. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. Regulatory Peptides. 13: 253-72. PMID 2422706 DOI: 10.1016/0167-0115(86)90044-3 |
0.258 |
|
| 2012 |
Hedman E, Ljótsson B, Lindefors N. Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness. Expert Review of Pharmacoeconomics & Outcomes Research. 12: 745-64. PMID 23252357 DOI: 10.1586/Erp.12.67 |
0.258 |
|
| 2008 |
Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, ... ... Lindefors N, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 371: 1085-97. PMID 18374841 DOI: 10.1016/S0140-6736(08)60486-9 |
0.257 |
|
| 2013 |
El Alaoui S, Hedman E, Ljótsson B, Bergström J, Andersson E, Rück C, Andersson G, Lindefors N. Predictors and moderators of internet- and group-based cognitive behaviour therapy for panic disorder. Plos One. 8: e79024. PMID 24244406 DOI: 10.1371/Journal.Pone.0079024 |
0.257 |
|
| 2011 |
Andersson E, Ljótsson B, Hedman E, Kaldo V, Paxling B, Andersson G, Lindefors N, Rück C. Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study. Bmc Psychiatry. 11: 125. PMID 21812991 DOI: 10.1186/1471-244X-11-125 |
0.256 |
|
| 2009 |
Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, ... ... Lindefors N, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). The American Journal of Psychiatry. 166: 675-82. PMID 19369319 DOI: 10.1176/Appi.Ajp.2008.08060806 |
0.255 |
|
| 2014 |
Andersson E, Ljótsson B, Hedman E, Hesser H, Enander J, Kaldo V, Andersson G, Lindefors N, Rück C. Testing the Mediating Effects of Obsessive Beliefs in Internet-Based Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder: Results from a Randomized Controlled Trial. Clinical Psychology & Psychotherapy. PMID 25418575 DOI: 10.1002/Cpp.1931 |
0.255 |
|
| 2012 |
Hedman E, Andersson E, Ljótsson B, Andersson G, Andersson E, Schalling M, Lindefors N, Rück C. Clinical and genetic outcome determinants of Internet- and group-based cognitive behavior therapy for social anxiety disorder. Acta Psychiatrica Scandinavica. 126: 126-36. PMID 22320999 DOI: 10.1111/J.1600-0447.2012.01834.X |
0.255 |
|
| 2019 |
Hagen EA, Crowley J, Kähler A, Karlsson R, Mattheisen M, Schalling M, Lavebratt C, Boberg J, Forsell E, Alaoui SE, Hedman E, Kaldo V, Lindefors N, Sullivan P, Ruck C. Genome Wide Association Study Of Treatment Response To Cognitive Behavioral Therapy For Depression European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.228 |
0.254 |
|
| 2012 |
Andersson E, Enander J, Andrén P, Hedman E, Ljótsson B, Hursti T, Bergström J, Kaldo V, Lindefors N, Andersson G, Rück C. Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychological Medicine. 42: 2193-203. PMID 22348650 DOI: 10.1017/S0033291712000244 |
0.252 |
|
| 2013 |
Lindefors N. 2518 – Internet-based treatment for mental disorders European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)77227-4 |
0.249 |
|
| 2015 |
Blom K, Tarkian Tillgren H, Wiklund T, Danlycke E, Forssén M, Söderström A, Johansson R, Hesser H, Jernelöv S, Lindefors N, Andersson G, Kaldo V. Internet-vs. group-delivered cognitive behavior therapy for insomnia: A randomized controlled non-inferiority trial. Behaviour Research and Therapy. 70: 47-55. PMID 25981329 DOI: 10.1016/J.Brat.2015.05.002 |
0.247 |
|
| 2010 |
Ljótsson B, Andréewitch S, Hedman E, Rück C, Andersson G, Lindefors N. Exposure and mindfulness based therapy for irritable bowel syndrome--an open pilot study. Journal of Behavior Therapy and Experimental Psychiatry. 41: 185-90. PMID 20079485 DOI: 10.1016/J.Jbtep.2010.01.001 |
0.246 |
|
| 2010 |
Ljótsson B, Falk L, Vesterlund AW, Hedman E, Lindfors P, Rück C, Hursti T, Andréewitch S, Jansson L, Lindefors N, Andersson G. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial. Behaviour Research and Therapy. 48: 531-9. PMID 20362976 DOI: 10.1016/J.Brat.2010.03.003 |
0.246 |
|
| 2014 |
Hedman E, Andersson G, Lindefors N, Gustavsson P, Lekander M, Rück C, Andersson E, Ljótsson B. Personality change following internet-based cognitive behavior therapy for severe health anxiety. Plos One. 9: e113871. PMID 25437150 DOI: 10.1371/Journal.Pone.0113871 |
0.246 |
|
| 2013 |
El Alaoui S, Hedman E, Ljótsson B, Bergström J, Lindefors N. 1153 – Effectiveness and health economic evaluation of internet-based cognitive behavioural therapy in regular psychiatric care European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76246-1 |
0.245 |
|
| 2013 |
Hedman E, Ljótsson B, Rück C, Bergström J, Andersson G, Kaldo V, Jansson L, Andersson E, Andersson E, Blom K, El Alaoui S, Falk L, Ivarsson J, Nasri B, Rydh S, ... Lindefors N, et al. Effectiveness of internet-based cognitive behaviour therapy for panic disorder in routine psychiatric care. Acta Psychiatrica Scandinavica. 128: 457-67. PMID 23406572 DOI: 10.1111/Acps.12079 |
0.245 |
|
| 2014 |
Hedman E, El Alaoui S, Lindefors N, Andersson E, Rück C, Ghaderi A, Kaldo V, Lekander M, Andersson G, Ljótsson B. Clinical effectiveness and cost-effectiveness of Internet- vs. group-based cognitive behavior therapy for social anxiety disorder: 4-year follow-up of a randomized trial. Behaviour Research and Therapy. 59: 20-9. PMID 24949908 DOI: 10.1016/J.Brat.2014.05.010 |
0.244 |
|
| 2009 |
Lonsdorf TB, Rück C, Bergström J, Andersson G, Ohman A, Schalling M, Lindefors N. The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1479-83. PMID 19683026 DOI: 10.1016/J.Pnpbp.2009.08.004 |
0.244 |
|
| 2011 |
Ljótsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, Rydh S, Rück C, Lindefors N, Andersson G. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. The American Journal of Gastroenterology. 106: 1481-91. PMID 21537360 DOI: 10.1038/Ajg.2011.139 |
0.243 |
|
| 2012 |
Enander J, Andersson E, Kaldo V, Lindefors N, Andersson G, Rück C. Internet administration of the Dimensional Obsessive-Compulsive Scale: A psychometric evaluation Journal of Obsessive-Compulsive and Related Disorders. 1: 325-330. DOI: 10.1016/J.Jocrd.2012.07.008 |
0.243 |
|
| 2014 |
Hedman E, Ljótsson B, Kaldo V, Hesser H, El Alaoui S, Kraepelien M, Andersson E, Rück C, Svanborg C, Andersson G, Lindefors N. Effectiveness of Internet-based cognitive behaviour therapy for depression in routine psychiatric care. Journal of Affective Disorders. 155: 49-58. PMID 24238951 DOI: 10.1016/J.Jad.2013.10.023 |
0.243 |
|
| 2013 |
Blom K, Jernelöv S, Kraepelien M, Lindefors N, Kaldo V. Is insomnia treatment superior to depression treatment for patients with both diagnoses? – Results of a randomized controlled trial Sleep Medicine. 14. DOI: 10.1016/J.Sleep.2013.11.054 |
0.242 |
|
| 2011 |
Ljótsson B, Andersson G, Andersson E, Hedman E, Lindfors P, Andréewitch S, Rück C, Lindefors N. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. Bmc Gastroenterology. 11: 110. PMID 21992655 DOI: 10.1186/1471-230X-11-110 |
0.242 |
|
| 2015 |
Andersson E, Hedman E, Enander J, Radu Djurfeldt D, Ljótsson B, Cervenka S, Isung J, Svanborg C, Mataix-Cols D, Kaldo V, Andersson G, Lindefors N, Rück C. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial. Jama Psychiatry. 72: 659-67. PMID 25970252 DOI: 10.1001/Jamapsychiatry.2015.0546 |
0.242 |
|
| 2016 |
El Alaoui S, Ljótsson B, Hedman E, Svanborg C, Kaldo V, Lindefors N. Predicting Outcome in Internet-Based Cognitive Behaviour Therapy for Major Depression: A Large Cohort Study of Adult Patients in Routine Psychiatric Care. Plos One. 11: e0161191. PMID 27618548 DOI: 10.1371/Journal.Pone.0161191 |
0.241 |
|
| 2013 |
Hedman E, Andersson E, Lindefors N, Andersson G, Rück C, Ljótsson B. Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety. Psychological Medicine. 43: 363-74. PMID 22608115 DOI: 10.1017/S0033291712001079 |
0.24 |
|
| 2017 |
Blom K, Jernelöv S, Rück C, Lindefors N, Kaldo V. Three-year follow-up comparing cognitive behavioral therapy for depression to cognitive behavioral therapy for insomnia, for patients with both diagnoses. Sleep. PMID 28655183 DOI: 10.1093/Sleep/Zsx108 |
0.24 |
|
| 2010 |
Hedman E, Ljótsson B, Andersson E, Rück C, Andersson G, Lindefors N. Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: an open trial. Cognitive Behaviour Therapy. 39: 239-50. PMID 20972912 DOI: 10.1080/16506073.2010.496460 |
0.239 |
|
| 2011 |
Hedman E, Andersson E, Ljótsson B, Andersson G, Rück C, Lindefors N. Cost-effectiveness of Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: results from a randomized controlled trial. Behaviour Research and Therapy. 49: 729-36. PMID 21851929 DOI: 10.1016/J.Brat.2011.07.009 |
0.239 |
|
| 2011 |
Hedman E, Andersson G, Andersson E, Ljótsson B, Rück C, Asmundson GJ, Lindefors N. Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. 198: 230-6. PMID 21357882 DOI: 10.1192/Bjp.Bp.110.086843 |
0.239 |
|
| 2008 |
Bergstroem J, Ljotsson B, Andersson G, Andreewitch S, Ruck C, Carlbring P, Lindefors N. Effectiveness of internet treatment for panic disorder delivered in a psychiatric setting European Psychiatry. 23: S355-S356. DOI: 10.1016/J.Eurpsy.2008.01.1230 |
0.238 |
|
| 2019 |
Kraepelien M, Svanborg C, Lallerstedt L, Sennerstam V, Lindefors N, Kaldo V. Individually tailored internet treatment in routine care: A feasibility study. Internet Interventions. 18: 100263. PMID 31890616 DOI: 10.1016/J.Invent.2019.100263 |
0.237 |
|
| 2013 |
Hedman E, Lindefors N, Andersson G, Andersson E, Lekander M, Rück C, Ljótsson B. Predictors of outcome in Internet-based cognitive behavior therapy for severe health anxiety. Behaviour Research and Therapy. 51: 711-7. PMID 23994252 DOI: 10.1016/J.Brat.2013.07.009 |
0.237 |
|
| 2015 |
El Alaoui S, Hedman E, Ljótsson B, Lindefors N. Long-term effectiveness and outcome predictors of therapist-guided internet-based cognitive-behavioural therapy for social anxiety disorder in routine psychiatric care. Bmj Open. 5: e007902. PMID 26105031 DOI: 10.1136/Bmjopen-2015-007902 |
0.237 |
|
| 2018 |
Hedman-Lagerlöf E, Bergman A, Lindefors N, Bradley M. Exposure-based cognitive behavior therapy for atopic dermatitis: an open trial. Cognitive Behaviour Therapy. 1-11. PMID 30192705 DOI: 10.1080/16506073.2018.1504320 |
0.237 |
|
| 2013 |
Andersson E, Rück C, Lavebratt C, Hedman E, Schalling M, Lindefors N, Eriksson E, Carlbring P, Andersson G, Furmark T. Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder. Plos One. 8: e79015. PMID 24260145 DOI: 10.1371/Journal.Pone.0079015 |
0.237 |
|
| 2011 |
Ljótsson B, Hedman E, Lindfors P, Hursti T, Lindefors N, Andersson G, Rück C. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behaviour Research and Therapy. 49: 58-61. PMID 21092934 DOI: 10.1016/J.Brat.2010.10.006 |
0.237 |
|
| 2014 |
Schibbye P, Ghaderi A, Ljótsson B, Hedman E, Lindefors N, Rück C, Kaldo V. Using early change to predict outcome in cognitive behaviour therapy: exploring timeframe, calculation method, and differences of disorder-specific versus general measures. Plos One. 9: e100614. PMID 24959666 DOI: 10.1371/Journal.Pone.0100614 |
0.236 |
|
| 2016 |
Blom K, Jernelöv S, Rück C, Lindefors N, Kaldo V. Three-Year Follow-up of Insomnia and Hypnotics After Controlled Internet Treatment for Insomnia. Sleep. PMID 27091535 DOI: 10.5665/Sleep.5850 |
0.236 |
|
| 2011 |
Hedman E, Furmark T, Carlbring P, Ljótsson B, Rück C, Lindefors N, Andersson G. A 5-Year follow-up of internet-based cognitive behavior therapy for social anxiety disorder. Journal of Medical Internet Research. 13: e39. PMID 21676694 DOI: 10.2196/Jmir.1776 |
0.236 |
|
| 2012 |
Ginsberg Y, Hirvikoski T, Grann M, Lindefors N. Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate. European Archives of Psychiatry and Clinical Neuroscience. 262: 705-24. PMID 22526730 DOI: 10.1007/S00406-012-0317-8 |
0.233 |
|
| 2011 |
Andersson E, Ljótsson B, Smit F, Paxling B, Hedman E, Lindefors N, Andersson G, Rück C. Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial. Bmc Public Health. 11: 215. PMID 21473754 DOI: 10.1186/1471-2458-11-215 |
0.233 |
|
| 2015 |
Andersson E, Ljótsson B, Hedman E, Mattson S, Enander J, Andersson G, Kaldo V, Lindefors N, Rück C. Cost-effectiveness of an internet-based booster program for patients with obsessive-compulsive disorder: Results from a randomized controlled trial Journal of Obsessive-Compulsive and Related Disorders. 4: 14-19. DOI: 10.1016/J.Jocrd.2014.10.002 |
0.233 |
|
| 2015 |
Andersson E, Hedman E, Ljótsson B, Wikström M, Elveling E, Lindefors N, Andersson G, Kaldo V, Rück C. Cost-effectiveness of internet-based cognitive behavior therapy for obsessive-compulsive disorder: Results from a randomized controlled trial Journal of Obsessive-Compulsive and Related Disorders. 4: 47-53. DOI: 10.1016/J.Jocrd.2014.12.004 |
0.233 |
|
| 2017 |
El Alaoui S, Hedman-Lagerlöf E, Ljótsson B, Lindefors N. Does internet-based cognitive behaviour therapy reduce healthcare costs and resource use in treatment of social anxiety disorder? A cost-minimisation analysis conducted alongside a randomised controlled trial. Bmj Open. 7: e017053. PMID 28899892 DOI: 10.1136/Bmjopen-2017-017053 |
0.233 |
|
| 2019 |
Forsell E, Isacsson N, Blom K, Jernelöv S, Ben Abdesslem F, Lindefors N, Boman M, Kaldo V. Predicting treatment failure in regular care Internet-Delivered Cognitive Behavior Therapy for depression and anxiety using only weekly symptom measures. Journal of Consulting and Clinical Psychology. PMID 31829635 DOI: 10.1037/Ccp0000462 |
0.232 |
|
| 2013 |
Hedman E, Andersson E, Andersson G, Lindefors N, Lekander M, Rück C, Ljótsson B. Mediators in internet-based cognitive behavior therapy for severe health anxiety. Plos One. 8: e77752. PMID 24147073 DOI: 10.1371/Journal.Pone.0077752 |
0.232 |
|
| 2015 |
Kaldo V, Jernelöv S, Blom K, Ljótsson B, Brodin M, Jörgensen M, Kraepelien M, Rück C, Lindefors N. Guided internet cognitive behavioral therapy for insomnia compared to a control treatment - A randomized trial. Behaviour Research and Therapy. 71: 90-100. PMID 26091917 DOI: 10.1016/J.Brat.2015.06.001 |
0.232 |
|
| 2018 |
Karyotaki E, Ebert DD, Donkin L, Riper H, Twisk J, Burger S, Rozental A, Lange A, Williams AD, Zarski AC, Geraedts A, van Straten A, Kleiboer A, Meyer B, Ünlü Ince BB, ... ... Lindefors N, et al. Do guided internet-based interventions result in clinically relevant changes for patients with depression? An individual participant data meta-analysis. Clinical Psychology Review. 63: 80-92. PMID 29940401 DOI: 10.1016/J.Cpr.2018.06.007 |
0.23 |
|
| 2015 |
Hallgren M, Kraepelien M, Öjehagen A, Lindefors N, Zeebari Z, Kaldo V, Forsell Y. Physical exercise and internet-based cognitive-behavioural therapy in the treatment of depression: randomised controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. 207: 227-34. PMID 26089305 DOI: 10.1192/Bjp.Bp.114.160101 |
0.23 |
|
| 2019 |
Andersson G, Carlbring P, Titov N, Lindefors N. Internet Interventions for Adults with Anxiety and Mood Disorders: A Narrative Umbrella Review of Recent Meta-Analyses. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743719839381. PMID 31096757 DOI: 10.1177/0706743719839381 |
0.23 |
|
| 2013 |
Vigerland S, Thulin U, Ljótsson B, Svirsky L, Ost LG, Lindefors N, Andersson G, Serlachius E. Internet-delivered CBT for children with specific phobia: a pilot study. Cognitive Behaviour Therapy. 42: 303-14. PMID 24245708 DOI: 10.1080/16506073.2013.844201 |
0.229 |
|
| 2014 |
Hedman E, Lekander M, Ljótsson B, Lindefors N, Rück C, Hofmann SG, Andersson E, Andersson G, Schulz SM. Sudden gains in internet-based cognitive behaviour therapy for severe health anxiety. Behaviour Research and Therapy. 54: 22-9. PMID 24468920 DOI: 10.1016/J.Brat.2013.12.007 |
0.229 |
|
| 2012 |
Ginsberg Y, Lindefors N. Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension. The British Journal of Psychiatry : the Journal of Mental Science. 200: 68-73. PMID 22075648 DOI: 10.1192/Bjp.Bp.111.092940 |
0.229 |
|
| 2016 |
Hallgren M, Helgadóttir B, Herring MP, Zeebari Z, Lindefors N, Kaldo V, Öjehagen A, Forsell Y. Exercise and internet-based cognitive-behavioural therapy for depression: multicentre randomised controlled trial with 12-month follow-up. The British Journal of Psychiatry : the Journal of Mental Science. PMID 27609813 DOI: 10.1192/Bjp.Bp.115.177576 |
0.228 |
|
| 2019 |
Rayner C, Coleman JRI, Purves KL, Hodsoll J, Goldsmith K, Alpers GW, Andersson E, Arolt V, Boberg J, Bögels S, Creswell C, Cooper P, Curtis C, Deckert J, Domschke K, ... ... Lindefors N, et al. A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders. Translational Psychiatry. 9: 150. PMID 31123309 DOI: 10.1038/S41398-019-0481-Y |
0.227 |
|
| 2014 |
Gajecki M, Berman AH, Sinadinovic K, Andersson C, Ljótsson B, Hedman E, Rück C, Lindefors N. Effects of baseline problematic alcohol and drug use on internet-based cognitive behavioral therapy outcomes for depression, panic disorder and social anxiety disorder. Plos One. 9: e104615. PMID 25122509 DOI: 10.1371/Journal.Pone.0104615 |
0.227 |
|
| 2015 |
Andersson E, Ljótsson B, Hedman E, Enander J, Kaldo V, Andersson G, Lindefors N, Rück C. Predictors and moderators of Internet-based cognitive behavior therapy for obsessive-compulsive disorder: Results from a randomized trial Journal of Obsessive-Compulsive and Related Disorders. 4: 1-7. DOI: 10.1016/J.Jocrd.2014.10.003 |
0.227 |
|
| 2019 |
Kraepelien M, Blom K, Lindefors N, Johansson R, Kaldo V. The effects of component-specific treatment compliance in individually tailored internet-based treatment. Clinical Psychology & Psychotherapy. PMID 30650232 DOI: 10.1002/Cpp.2351 |
0.226 |
|
| 2018 |
Andersson E, Crowley JJ, Lindefors N, Ljótsson B, Hedman-Lagerlöf E, Boberg J, El Alaoui S, Karlsson R, Lu Y, Mattheisen M, Kähler AK, Svanborg C, Mataix-Cols D, Mattsson S, Forsell E, et al. Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report. Molecular Psychiatry. PMID 30410065 DOI: 10.1038/S41380-018-0289-9 |
0.226 |
|
| 2015 |
Kraepelien M, Svenningsson P, Lindefors N, Kaldo V. Internet-based cognitive behavioral therapy for depression and anxiety in parkinson's disease - a pilot study Internet Interventions. 2: 1-6. DOI: 10.1016/J.Invent.2014.11.006 |
0.226 |
|
| 2016 |
Blom K, Jernelöv S, Lindefors N, Kaldo V. Facilitating and hindering factors in Internet-delivered treatment for insomnia and depression. Internet Interventions. 4: 51-60. PMID 30135790 DOI: 10.1016/J.Invent.2016.03.004 |
0.226 |
|
| 2013 |
Hedman E, Ljótsson B, Blom K, El Alaoui S, Kraepelien M, Rück C, Andersson G, Svanborg C, Lindefors N, Kaldo V. Telephone versus internet administration of self-report measures of social anxiety, depressive symptoms, and insomnia: psychometric evaluation of a method to reduce the impact of missing data. Journal of Medical Internet Research. 15: e229. PMID 24140566 DOI: 10.2196/Jmir.2818 |
0.226 |
|
| 2013 |
Ljótsson B, Hesser H, Andersson E, Lindfors P, Hursti T, Rück C, Lindefors N, Andersson G, Hedman E. Mechanisms of change in an exposure-based treatment for irritable bowel syndrome. Journal of Consulting and Clinical Psychology. 81: 1113-26. PMID 23750460 DOI: 10.1037/A0033439 |
0.224 |
|
| 2014 |
Andersson E, Steneby S, Karlsson K, Ljótsson B, Hedman E, Enander J, Kaldo V, Andersson G, Lindefors N, Rück C. Long-term efficacy of Internet-based cognitive behavior therapy for obsessive-compulsive disorder with or without booster: a randomized controlled trial. Psychological Medicine. 44: 2877-87. PMID 25066102 DOI: 10.1017/S0033291714000543 |
0.224 |
|
| 2016 |
El Alaoui S, Lindefors N. Combining Time-Driven Activity-Based Costing with Clinical Outcome in Cost-Effectiveness Analysis to Measure Value in Treatment of Depression. Plos One. 11: e0165389. PMID 27798655 DOI: 10.1371/Journal.Pone.0165389 |
0.224 |
|
| 2013 |
Ginsberg Y, Hirvikoski T, Grann M, Lindefors N. 1465 – Osmotic-release oral system methylphenidate (oros-mph) treatment of adult prison inmates with adhd: a randomised controlled trial with open-label extension European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76493-9 |
0.223 |
|
| 2019 |
Forsell E, Jernelöv S, Blom K, Kraepelien M, Svanborg C, Andersson G, Lindefors N, Kaldo V. Proof of Concept for an Adaptive Treatment Strategy to Prevent Failures in Internet-Delivered CBT: A Single-Blind Randomized Clinical Trial With Insomnia Patients. The American Journal of Psychiatry. appiajp201818060699. PMID 30696270 DOI: 10.1176/Appi.Ajp.2018.18060699 |
0.223 |
|
| 2017 |
Nasri B, Castenfors M, Fredlund P, Ginsberg Y, Lindefors N, Kaldo V. Group Treatment for Adults With ADHD Based on a Novel Combination of Cognitive and Dialectical Behavior Interventions. Journal of Attention Disorders. 1087054717690231. PMID 28178870 DOI: 10.1177/1087054717690231 |
0.221 |
|
| 2015 |
Blom K, Jernelöv S, Kraepelien M, Bergdahl MO, Jungmarker K, Ankartjärn L, Lindefors N, Kaldo V. Internet treatment addressing either insomnia or depression, for patients with both diagnoses: a randomized trial. Sleep. 38: 267-77. PMID 25337948 DOI: 10.5665/Sleep.4412 |
0.217 |
|
| 2015 |
Moëll B, Kollberg L, Nasri B, Lindefors N, Kaldo V. Living smart - a randomized controlled trial of a guided online course teaching adults with adhd or sub-clinical adhd to use smartphones to structure their everyday life Internet Interventions. 2: 24-31. DOI: 10.1016/J.Invent.2014.11.004 |
0.216 |
|
| 2020 |
Kraepelien M, Schibbye R, Månsson K, Sundström C, Riggare S, Andersson G, Lindefors N, Svenningsson P, Kaldo V. Individually Tailored Internet-Based Cognitive-Behavioral Therapy for Daily Functioning in Patients with Parkinson's Disease: A Randomized Controlled Trial. Journal of Parkinson's Disease. PMID 32176657 DOI: 10.3233/Jpd-191894 |
0.216 |
|
| 2010 |
Hedman E, Ljótsson B, Rück C, Furmark T, Carlbring P, Lindefors N, Andersson G. Internet administration of self-report measures commonly used in research on social anxiety disorder: A psychometric evaluation Computers in Human Behavior. 26: 736-740. DOI: 10.1016/J.Chb.2010.01.010 |
0.211 |
|
| 2015 |
Hedman E, Lekander M, Ljótsson B, Lindefors N, Rück C, Andersson G, Andersson E. Optimal cut-off points on the health anxiety inventory, illness attitude scales and whiteley index to identify severe health anxiety. Plos One. 10: e0123412. PMID 25849477 DOI: 10.1371/Journal.Pone.0123412 |
0.208 |
|
| 2019 |
Hagen EA, Crowley J, Lindefors N, Ljótsson B, Hedman E, Boberg J, Karlsson R, Li Y, Mattheisen M, Kahler A, Mataix-Cols D, Schalling M, Lavebratt C, Sullivan P, Ruck C. Genetics Of Response To Cognitive Behavior Therapy In Adults With Major Depression European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.07.052 |
0.207 |
|
| 2011 |
Lonsdorf TB, Rück C, Bergström J, Andersson G, Öhman A, Schalling M, Lindefors N. Erratum to "The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism" [Prog Neuro-Psychopharmacol Biol Psychiatry 33(2009) 1479-1483] Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35: 312. DOI: 10.1016/J.Pnpbp.2010.09.004 |
0.205 |
|
| 2015 |
Ginsberg Y, Långström N, Larsson H, Lindefors N. Long-Term Treatment Outcome in Adult Male Prisoners With Attention-Deficit/Hyperactivity Disorder: Three-Year Naturalistic Follow-Up of a 52-Week Methylphenidate Trial. Journal of Clinical Psychopharmacology. 35: 535-43. PMID 26284932 DOI: 10.1097/Jcp.0000000000000395 |
0.204 |
|
| 2010 |
Ginsberg Y, Hirvikoski T, Lindefors N. Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. Bmc Psychiatry. 10: 112. PMID 21176203 DOI: 10.1186/1471-244X-10-112 |
0.204 |
|
| 1993 |
Vezzani A, Ruiz R, Monno A, Rizzi M, Lindefors N, Samanin R, Brodin E. Extracellular somatostatin measured by microdialysis in the hippocampus of freely moving rats: evidence for neuronal release. Journal of Neurochemistry. 60: 671-7. PMID 8093481 |
0.204 |
|
| 2010 |
Ljótsson B, Falk L, Hedman E, Lindfors P, Hursti T, Rück C, Andréewitch S, Jansson L, Lindefors N, Andersson G. W1375 Internet-Delivered Cognitive Behavior Therapy for Irritable Bowel Syndrome -A Randomized Controlled Trial Gastroenterology. 138: S-710. DOI: 10.1016/S0016-5085(10)63266-0 |
0.199 |
|
| 2015 |
Hedman E, Ljótsson B, Andersson E, Andersson G, Lindefors N, Rück C, Axelsson E, Lekander M. Psychometric properties of Internet-administered measures of health anxiety: an investigation of the Health Anxiety Inventory, the Illness Attitude Scales, and the Whiteley Index. Journal of Anxiety Disorders. 31: 32-7. PMID 25723780 DOI: 10.1016/J.Janxdis.2015.01.008 |
0.199 |
|
| 2002 |
Radu D, Åhlin A, Svanborg P, Lindefors N. Pentagastrin, anxiety and personality European Psychiatry. 17: 51. DOI: 10.1016/S0924-9338(02)80230-9 |
0.195 |
|
| 2016 |
Tiger M, Farde L, Rück C, Varrone A, Forsberg A, Lindefors N, Halldin C, Lundberg J. Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder. Psychiatry Research. 253: 36-42. PMID 27269199 DOI: 10.1016/J.Pscychresns.2016.04.016 |
0.194 |
|
| 1998 |
Lindefors N. CCK receptors in the brain as targets for new antipsychotic drugs Schizophrenia Research. 29: 168-169. DOI: 10.1016/S0920-9964(97)88737-3 |
0.191 |
|
| 2002 |
Lindefors N. What can Internet add to psychiatry? European Psychiatry. 17: 70. DOI: 10.1016/S0924-9338(02)80319-4 |
0.184 |
|
| 1999 |
Hurd Y, Lindefors N. [Increasing abuse of psychostimulants is alarming. New findings confirm the mechanisms behind cocaine and amphetamine addiction]. Lã¤Kartidningen. 96: 1814-6, 1819-21. PMID 10319645 |
0.163 |
|
| 1985 |
Brodin E, Lindefors N, Theodorsson-Norheim E. Tachykinins in rat central nervous system: Distribution, molecular forms, release and effects of chronic treatment with antidepressant drugs Fernstrom Foundation Series. 15-27. |
0.143 |
|
| 2017 |
Tangen Ä, Borg J, Tiger M, Varnäs K, Sorjonen K, Lindefors N, Halldin C, Lundberg J. Associations between cognition and serotonin receptor 1B binding in patients with major depressive disorder - A pilot study. Psychiatry Research. 267: 15-21. PMID 28688337 DOI: 10.1016/J.Pscychresns.2017.06.001 |
0.141 |
|
| 2017 |
Lindefors N, El Alaoui S, Svanborg C. Lakartidningen. 114. PMID 28140422 |
0.12 |
|
| 2024 |
Kraepelien M, Lindefors N, Hentati A, Kern D, Forsell E, Kaldo V, Ljótsson B. [CBT administered via the internet]. Lakartidningen. 121. PMID 38411547 |
0.12 |
|
| 2021 |
Schiele MA, Reif A, Lin J, Alpers GW, Andersson E, Andersson G, Arolt V, Bergström J, Carlbring P, Eley TC, Esquivel G, Furmark T, Gerlach AL, Hamm A, Helbig-Lang S, ... ... Lindefors N, et al. Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 33483252 DOI: 10.1016/j.euroneuro.2021.01.004 |
0.103 |
|
| 2023 |
Nasri B, Cassel M, Enhärje J, Larsson M, Hirvikoski T, Ginsberg Y, Lindefors N, Kaldo V. Internet delivered cognitive behavioral therapy for adults with ADHD - A randomized controlled trial. Internet Interventions. 33: 100636. PMID 37483263 DOI: 10.1016/j.invent.2023.100636 |
0.102 |
|
| 2007 |
Lindefors N. Can we benefit from internet to increase accessibility to an effective non-pharmacological treatment for major depression and anxiety disorders? European Psychiatry. 22: S61-S62. DOI: 10.1016/j.eurpsy.2007.01.239 |
0.096 |
|
| 2008 |
Gospic K, Gunnarsson T, Fransson P, Ingvar M, Lindefors N, Petrovic P. Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology. 197: 295-307. PMID 18071677 DOI: 10.1007/s00213-007-1032-4 |
0.096 |
|
| 2010 |
Lonsdorf TB, Rück C, Bergström J, Andersson G, Ohman A, Lindefors N, Schalling M. The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder. Bmc Psychiatry. 10: 99. PMID 21110842 DOI: 10.1186/1471-244X-10-99 |
0.095 |
|
| 2015 |
El Alaoui S, Hedman E, Kaldo V, Hesser H, Kraepelien M, Andersson E, Rück C, Andersson G, Ljótsson B, Lindefors N. Effectiveness of Internet-based cognitive-behavior therapy for social anxiety disorder in clinical psychiatry. Journal of Consulting and Clinical Psychology. 83: 902-14. PMID 26009780 DOI: 10.1037/a0039198 |
0.093 |
|
| 2019 |
Rahman MS, Zhao X, Liu JJ, Torres EQ, Tibert B, Kumar P, Kaldo V, Lindefors N, Forsell Y, Lavebratt C. Exercise Reduces Salivary Morning Cortisol Levels in Patients with Depression. Molecular Neuropsychiatry. 4: 196-203. PMID 30815455 DOI: 10.1159/000494699 |
0.091 |
|
| 2022 |
Jernelöv S, Forsell E, Westman H, Eriksson Dufva Y, Lindefors N, Kaldo V, Kraepelien M. Treatment feasibility of a digital tool for brief self-help behavioural therapy for insomnia (FastAsleep). Journal of Sleep Research. e13759. PMID 36303518 DOI: 10.1111/jsr.13759 |
0.091 |
|
| 2018 |
Kraepelien M, Forsell E, Karin E, Johansson R, Lindefors N, Kaldo V. Comparing individually tailored to disorder-specific internet-based cognitive-behavioural therapy: benchmarking study. Bjpsych Open. 4: 282-284. PMID 30083380 DOI: 10.1192/bjo.2018.41 |
0.075 |
|
| 2017 |
Kaldo V, Lundin A, Hallgren M, Kraepelien M, Strid C, Ekblom Ö, Lavebratt C, Lindefors N, Öjehagen A, Forsell Y. Effects of internet-based cognitive behavioural therapy and physical exercise on sick leave and employment in primary care patients with depression: two subgroup analyses. Occupational and Environmental Medicine. PMID 28951431 DOI: 10.1136/oemed-2017-104326 |
0.075 |
|
| 2021 |
Wallén H, Lindfors P, Andersson E, Hedman-Lagerlöf E, Hesser H, Lindefors N, Svanborg C, Ljótsson B. Return on investment of internet delivered exposure therapy for irritable bowel syndrome: a randomized controlled trial. Bmc Gastroenterology. 21: 289. PMID 34256715 DOI: 10.1186/s12876-021-01867-6 |
0.073 |
|
| 2005 |
Andersson G, Bergström J, Carlbring P, Lindefors N. The use of the Internet in the treatment of anxiety disorders. Current Opinion in Psychiatry. 18: 73-7. PMID 16639187 |
0.072 |
|
| 2015 |
Kaldo V, Jernelöv S, Blom K, Ljótsson B, Brodin M, Jörgensen M, Kraepelien M, Rück C, Lindefors N. Guided internet cognitive behavioral therapy for insomnia compared to a control treatment - A randomized trial Behaviour Research and Therapy. 71: 90-100. DOI: 10.1016/j.brat.2015.06.001 |
0.07 |
|
| 2021 |
Karyotaki E, Efthimiou O, Miguel C, Bermpohl FMG, Furukawa TA, Cuijpers P, Riper H, Patel V, Mira A, Gemmil AW, Yeung AS, Lange A, Williams AD, Mackinnon A, ... ... Lindefors N, et al. Internet-Based Cognitive Behavioral Therapy for Depression: A Systematic Review and Individual Patient Data Network Meta-analysis. Jama Psychiatry. PMID 33471111 DOI: 10.1001/jamapsychiatry.2020.4364 |
0.064 |
|
| 2018 |
Titov N, Dear B, Nielssen O, Staples L, Hadjistavropoulos H, Nugent M, Adlam K, Nordgreen T, Bruvik KH, Hovland A, Repål A, Mathiasen K, Kraepelien M, Blom K, Svanborg C, ... Lindefors N, et al. ICBT in routine care: A descriptive analysis of successful clinics in five countries. Internet Interventions. 13: 108-115. PMID 30206525 DOI: 10.1016/j.invent.2018.07.006 |
0.062 |
|
| 2022 |
Hentati A, Forsell E, Ljótsson B, Lindefors N, Kraepelien M. A self-guided and monitored digital problem-solving intervention for patients with symptoms of depression or anxiety on the waiting list for treatment in routine psychiatric care: feasibility study. Bjpsych Open. 8: e43. PMID 35130998 DOI: 10.1192/bjo.2022.14 |
0.061 |
|
| 2013 |
Vigerland S, Thulin U, Ljótsson B, Svirsky L, Bengtsson O, Lindefors N, Andersson G, Serlachius E. [Computerized therapy for anxiety disorders should also be considered for children and adolescents. Can give better access to evidence-based treatment]. Lã¤Kartidningen. 110: 92-4. PMID 23424987 |
0.06 |
|
| 2018 |
Kraepelien M, Mattsson S, Hedman-Lagerlöf E, Petersson IF, Forsell Y, Lindefors N, Kaldo V. Cost-effectiveness of internet-based cognitive-behavioural therapy and physical exercise for depression. Bjpsych Open. 4: 265-273. PMID 30057780 DOI: 10.1192/bjo.2018.38 |
0.059 |
|
| 2018 |
Kraepelien M, Mattsson S, Hedman-Lagerlöf E, Petersson IF, Forsell Y, Lindefors N, Kaldo V. Cost-effectiveness of internet-based cognitive-behavioural therapy and physical exercise for depression. Bjpsych Open. 4: 265-273. PMID 30057780 DOI: 10.1192/bjo.2018.38 |
0.059 |
|
| 2023 |
Kern D, Ljótsson B, Lönndahl L, Hedman-Lagerlöf E, Bradley M, Lindefors N, Kraepelien M. Brief self-guided digital intervention versus a comprehensive therapist-guided online cognitive behavioural therapy for atopic dermatitis: a trial protocol for a randomised non-inferiority trial. Bmj Open. 13: e068908. PMID 36854583 DOI: 10.1136/bmjopen-2022-068908 |
0.059 |
|
| 2023 |
Boberg J, Kaldo V, Mataix-Cols D, Crowley JJ, Roelstraete B, Halvorsen M, Forsell E, Isacsson NH, Sullivan PF, Svanborg C, Andersson EH, Lindefors N, Kravchenko O, Mattheisen M, Danielsdottir HB, et al. Swedish multimodal cohort of patients with anxiety or depression treated with internet-delivered psychotherapy (MULTI-PSYCH). Bmj Open. 13: e069427. PMID 37793927 DOI: 10.1136/bmjopen-2022-069427 |
0.058 |
|
| 2023 |
Kern D, Ljótsson B, Lönndahl L, Hedman-Lagerlöf E, Bradley M, Lindefors N, Kraepelien M. A Digital Self-help Intervention for Atopic Dermatitis: Analysis of Secondary Outcomes From a Feasibility Study. Jmir Dermatology. 6: e42360. PMID 37632924 DOI: 10.2196/42360 |
0.056 |
|
| 2022 |
Hentati A, Forsell E, Ljótsson B, Lindefors N, Kraepelien M. A self-guided and monitored digital problem-solving intervention for patients with symptoms of depression or anxiety on the waiting list for treatment in routine psychiatric care: feasibility study - CORRIGENDUM. Bjpsych Open. 8: e115. PMID 35722778 DOI: 10.1192/bjo.2022.72 |
0.054 |
|
| 2009 |
Msghina M, Lindefors N. [Antipsychotic agents are best chosen by their adverse effect profile]. Lã¤Kartidningen. 106: 2841-2, 2844-6. PMID 19967963 |
0.054 |
|
| 2007 |
Ek M, Lindefors N. [Antipsychotics--clever choices]. Lã¤Kartidningen. 104: 504-8. PMID 17375681 |
0.053 |
|
| 2016 |
Andersson E, Rück C, Lavebratt C, Hedman E, Schalling M, Lindefors N, Eriksson E, Carlbring P, Andersson G, Furmark T. Correction: Genetic Polymorphisms in Monoamine Systems and Outcome of Cognitive Behavior Therapy for Social Anxiety Disorder. Plos One. 11: e0165249. PMID 27755589 DOI: 10.1371/journal.pone.0165249 |
0.051 |
|
| 2021 |
Hentati A, Forsell E, Ljótsson B, Kaldo V, Lindefors N, Kraepelien M. The effect of user interface on treatment engagement in a self-guided digital problem-solving intervention: A randomized controlled trial. Internet Interventions. 26: 100448. PMID 34471610 DOI: 10.1016/j.invent.2021.100448 |
0.049 |
|
| 2021 |
Hedman-Lagerlöf E, Fust J, Axelsson E, Bonnert M, Lalouni M, Molander O, Agrell P, Bergman A, Lindefors N, Bradley M. Internet-Delivered Cognitive Behavior Therapy for Atopic Dermatitis: A Randomized Clinical Trial. Jama Dermatology. PMID 34009282 DOI: 10.1001/jamadermatol.2021.1450 |
0.047 |
|
| 2022 |
Kern D, Ljótsson B, Bonnert M, Lindefors N, Kraepelien M. Online Guided Self-help Cognitive Behavioral Therapy With Exposure to Anxiety and Problem Solving in Type 1 Diabetes Mellitus: Case Study. Jmir Formative Research. 6: e32950. PMID 35830220 DOI: 10.2196/32950 |
0.045 |
|
| 2011 |
Lindefors N, Andersson G. [Anxiety is our heritage and we should administer it well]. Lã¤Kartidningen. 108: 785. PMID 21638915 |
0.042 |
|
| 2022 |
Österman S, Axelsson E, Lindefors N, Hedman-Lagerlöf E, Hedman-Lagerlöf M, Kern D, Svanborg C, Ivanov VZ. The 14-item short health anxiety inventory (SHAI-14) used as a screening tool: appropriate interpretation and diagnostic accuracy of the Swedish version. Bmc Psychiatry. 22: 701. PMID 36376898 DOI: 10.1186/s12888-022-04367-3 |
0.041 |
|
| 2018 |
Blomdahl Wetterholm M, Bendix M, Pettersson K, Lindefors N. [A Swedish example of integrated perinatal mental health care]. Lakartidningen. 115. PMID 30226630 |
0.039 |
|
| 2023 |
Österman S, Hentati A, Forsell E, Axelsson E, Hedman-Lagerlöf E, Lindefors N, Ivanov VZ, Kraepelien M. Brief digital self-care intervention for health anxiety in a Swedish Medical University Clinic: a prospective single-group feasibility study. Bmj Open. 13: e077376. PMID 38135329 DOI: 10.1136/bmjopen-2023-077376 |
0.038 |
|
| 2022 |
Hentati A, Forsell E, Ljótsson B, Kaldo V, Lindefors N, Kraepelien M. Corrigendum to "The effect of user interface on treatment engagement in a self-guided digital problem-solving intervention: A randomized controlled trial" [Internet Interv. 26 (2021) 1-10/100448]. Internet Interventions. 29: 100550. PMID 36092990 DOI: 10.1016/j.invent.2022.100550 |
0.037 |
|
| 2019 |
Forstner AJ, Awasthi S, Wolf C, Maron E, Erhardt A, Czamara D, Eriksson E, Lavebratt C, Allgulander C, Friedrich N, Becker J, Hecker J, Rambau S, Conrad R, Geiser F, ... ... Lindefors N, et al. Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression. Molecular Psychiatry. PMID 31712720 DOI: 10.1038/S41380-019-0590-2 |
0.036 |
|
| 2023 |
Kraepelien M, Hentati A, Kern D, Sundström C, Jernelöv S, Lindefors N. Transforming guided internet interventions into simplified and self-guided digital tools - Experiences from three recent projects. Internet Interventions. 34: 100693. PMID 38073676 DOI: 10.1016/j.invent.2023.100693 |
0.029 |
|
| 2001 |
Lindefors N. [New neuroleptics--better effects or better marketing?]. Lã¤Kartidningen. 98: 4469. PMID 11699254 |
0.028 |
|
| 2006 |
Ruud T, Lindefors N, Lindhardt A. Current issues in Scandinavian acute psychiatric wards. Epidemiologia E Psichiatria Sociale. 15: 99-103. PMID 16865929 |
0.025 |
|
| 2009 |
Bergström J, Andersson G, Lindefors N. Vetenskapligt stöd för vägledd KBT-baserad självhjälp vid depression via internet kan fler få behandling Lakartidningen. 106: 282-286. PMID 19271457 |
0.023 |
|
| 2011 |
Rück C, Ljótsson B, Lindefors N, Melin B. Nu kan du få en ganska overksam behandling som bonus till Cipralex Lakartidningen. 108. |
0.023 |
|
| 2011 |
Von Knorring L, Andersson G, Lichtenstein P, Rück C, Lindefors N. [Common early-onset diseases]. Lã¤Kartidningen. 108: 787-91. PMID 21638917 |
0.022 |
|
| 1993 |
Series H, Lindefors N. [Ecstasy--effects and toxicity. Distinct risks but uncertain long-term hazards]. Lã¤Kartidningen. 90: 2648-52. PMID 8103135 |
0.02 |
|
| 2009 |
Lindefors N. Långtidsbehandling med antipsykotika halverar mortaliteten vid schizofreni Lakartidningen. 106: 2828. |
0.02 |
|
| 2011 |
Rück C, Andersson EM, Andréewitch S, Bejerot S, Ivarsson T, Bates S, Lindefors N. [Again and again--the obsessive circle can be broken]. Lã¤Kartidningen. 108: 798-801. PMID 21638920 |
0.019 |
|
| 2022 |
Kern D, Ljótsson B, Lönndahl L, Hedman-Lagerlöf E, Bradley M, Lindefors N, Kraepelien M. Optimized User Experience, Efficiency, and Resource Use in Online Self-Management of Atopic Dermatitis. Jama Dermatology. PMID 36169936 DOI: 10.1001/jamadermatol.2022.3434 |
0.015 |
|
| 2011 |
Andersson G, Lindefors N. Är inte ert inlägg ett exempel på det ni säger er vara emot? Lakartidningen. 108: 996-997. |
0.015 |
|
| 2011 |
Rück C, Lindefors N, Allgulander C, Andersson G. [New research tracks pave the way for better therapy]. Lã¤Kartidningen. 108: 806-8. PMID 21638922 |
0.013 |
|
| 2011 |
Andersson G, Carlbring P, Svanborg C, Bergström J, Ost LG, Lindefors N. [Panic syndrome--evil circle of incorrectly interpreted bodily signals]. Lã¤Kartidningen. 108: 795-7. PMID 21638919 |
0.01 |
|
| 2011 |
Lindefors N, Andersson G. Ångest är vår arvedel som vi bör förvalta väl Lakartidningen. 108: 785. |
0.01 |
|
| 2001 |
Lindefors N. Nya neuroleptika - Bättre effekter eller bättre marknadsföring? Lakartidningen. 98: 4469. |
0.01 |
|
| Hide low-probability matches. |